US Edition
Billionaire Mehta Brothers’ Torrent To Buy Stake In India’s JB Pharma In $1.4 Billion Deal
- On June 29, 2025, Torrent Pharmaceuticals disclosed that it has finalized agreements with KKR to purchase a controlling interest in JB Chemicals and Pharmaceuticals.
- Torrent's acquisition followed KKR's ownership via Tau Investment Holdings, reflecting KKR's strategic guidance and JB Pharma's fast growth in India.
- The deal includes buying 46.39% stake at ₹1,600 per share for ₹11,917 crore, 2.8% from employees, and an open offer for 26% at ₹1,639.18 per share.
- JB Pharma shares closed 2.72% higher at ₹1,799.35 on the previous Friday after strong five-year returns of over 398%, despite a slight 0.03% one-year decline.
- The acquisition aims to merge the two companies, strengthen Torrent’s Indian market presence, expand into new segments, and build a future-ready diversified healthcare platform.
Insights by Ground AI
Does this summary seem wrong?
30 Articles
30 Articles
All
Left
3
Center
6
Right
6
Torrent Pharma's Strategic Acquisition Boost
Torrent Pharma's Strategic Acquisition Boost In a significant move within the pharmaceutical sector, India's Torrent Pharmaceuticals announced its plan to acquire a 46.39% controlling stake in JB Chemicals and Pharmaceuticals. The stake is being purchased from the New York-based investment firm KKR.The acquisition, part of a merger plan outlined by the companies, represents a strategic effort to consolidate operations. The joint announcement fro…
·India
Read Full Article
Coverage Details
Total News Sources30
Leaning Left3Leaning Right6Center6Last UpdatedBias Distribution40% Center, 40% Right
Bias Distribution
- 40% of the sources are Center, 40% of the sources lean Right
40% Right
L 20%
C 40%
R 40%
Factuality
To view factuality data please Upgrade to Premium
